Submitted:
19 November 2025
Posted:
21 November 2025
You are already at the latest version
Abstract

Keywords:
1. Introduction
2. Materials and Methods
2.1. Study Protocol
2.2. Subgroup Classification
2.3. Variables Analysis
2.4. Statistical Analysis
2.5. Ethical Compliance Statement
3. Results
Comparing with Prior Studies
4. Discussion
5. Conclusions
Author Contributions
Funding
Data Availability Statement
Conflict of Interest
References
- Masrori, P.; Van Damme, P. Amyotrophic lateral sclerosis: a clinical review. Eur. J. Neurol. 2020, 27, 1918–1929. [Google Scholar] [CrossRef]
- Niedermeyer, S.; Murn, M.; Choi, P.J. Respiratory failure in amyotrophic lateral sclerosis. Chest 2019, 155, 401–408. [Google Scholar] [CrossRef]
- Xu, K.; Ji, H.; Hu, N. Cardiovascular comorbidities in amyotrophic lateral sclerosis: A systematic review. J. Clin. Neurosci. 2022, 96, 43–49. [Google Scholar] [CrossRef] [PubMed]
- Feldman, E.L.; Goutman, S.A.; Petri, S.; Mazzini, L.; Savelieff, M.G.; Shaw, P.J.; Sobue, G. Amyotrophic lateral sclerosis. Lancet. 2022, 400, 1363–1380. [Google Scholar] [CrossRef] [PubMed]
- Gromicho, M.; Figueiral, M.; Uysal, H.; Grosskreutz, J.; Magdalena Kuzma-Kozakiewicz, M.; Pinto, S.; Petri, S.; Madeira, S.; Swash, M.; de Carvalho, M. Spreading in ALS: The relative impact of upper and lower motor neuron involvement. Ann. Clin. Transl. Neurol. 2020, 7, 1181–1192. [Google Scholar] [CrossRef] [PubMed]
- Couratier, P.; Lautrette, G.; Luna, J.A.; Corcia, P. Phenotypic variability in amyotrophic lateral sclerosis. Rev. Neurol. 2021, 177, 536–543. [Google Scholar] [CrossRef]
- De Carvalho, M.; Swash, M. Diagnosis and differential diagnosis of MND/ALS: IFCN handbook chapter. Clin. Neurophysiol. Pract. 2024, 7, 27–38. [Google Scholar] [CrossRef]
- Van Es, M.A.; Hardiman, O.; Chio, A.; Al-Chalabi, A.; Pasterkamp, R.J.; Veldink, J.H.; Van den Berg, L. ;. Amyotrophic lateral sclerosis. Lancet 2017, 390, 2084–2098. [Google Scholar] [CrossRef]
- Kraemer, M.; Buerger, M.; Berlit, P. Diagnostic problems and delay of diagnosis in amyotrophic lateral sclerosis. Clinical Neurology and Neurosurgery 2010, 112, 103–105. [Google Scholar] [CrossRef]
- Pinto, S.; Swash, M.; De Carvalho, M. Does surgery accelerate progression of amyotrophic lateral sclerosis? J. Neurol. Neurosurg. Psychiatry 2014, 85, 643–646. [Google Scholar] [CrossRef]
- Richards, D.; Morren, J.A.; Pioro, E.P. Time to diagnosis and factors affecting diagnostic delay in amyotrophic lateral sclerosis. J. Neurol. Sci. 2020, 417, 117054. [Google Scholar] [CrossRef]
- Cellura, E.; Spataro, R.; Taiello, A.C. ; La Bella, V Factors affecting the diagnostic delay in amyotrophic lateral sclerosis. Clin. Neurol. Neurosurg. 2012, 114, 550–554. [Google Scholar] [CrossRef]
- Gwathmey, K.G.; Corcia, P.; McDermott, C.J.; Genge, A.; Sennfält, S.; de Carvalho, M.; Ingre, C. Diagnostic delay in amyotrophic lateral sclerosis. Eur. J. Neurol. 2023, 30, 2595–2601. [Google Scholar] [CrossRef] [PubMed]
- Nzwalo, H.; De Abreu, D.; Swash, M.; et al. Delayed diagnosis in ALS: The problem continues. J. Neurol. Sci. 2014, 343, 173–175. [Google Scholar] [CrossRef] [PubMed]
- Falcão de Campos, C.; Gromicho, M.; Uysal, H.; Grosskreutz, J.; Kuzma-Kozakiewicz, M.; Oliveira Santos, M.; Pinto, S.; Petri, S.; Swash, M.; de Carvalho, M. Delayed Diagnosis and Diagnostic Pathway of ALS Patients in Portugal: Where Can We Improve? Front. Neurol. 2021, 12, 761355. [Google Scholar] [CrossRef] [PubMed]
- Bakola, E.; Konotis, P.; Zambelis, T.; Karandreas, N. Inappropriate surgeries in amyotrophic lateral sclerosis: A still considerable issue. Amyotroph. Lateral Scler. Frontotemporal Degener. 2014, 15, 315–317. [Google Scholar] [CrossRef]
- Srinivasan, J.; Scala, S.; Jones, H.R.; saleh, F.; Russell, J. J Inappropriate surgeries resulting from misdiagnosis of early amyotrophic lateral sclerosis. Muscle Nerve 2006, 34, 359–360. [Google Scholar] [CrossRef]
- De Carvalho, M.; Ryczkowski, A.; Andersen, P.; Gromicho, M.; Grosskreutz, J.; Kuźma-Kozakiewicz, M. ; Petri, S; Piotrkiewicz, M; Miltenberger Miltenyi, G International Survey of ALS Experts about Critical Questions for Assessing Patients with ALS. Amyotroph. Lateral Scler. Frontotemporal Degener. 2017, 18, 505–510. [Google Scholar] [CrossRef]
- Alves, I.; Gromicho, M.; Oliveira Santos, M.; Pinto, S.; de Carvalho, M. Assessing disease progression in ALS: prognostic subgroups and outliers. Amyotroph. Lateral Scler. Frontotemporal Degener. 2025, 26, 58–63. [Google Scholar] [CrossRef]
- Paganoni, S.; Macklin, E.A.; Lee, A.; Murphy, A.; Chang, J.; Zipf, A.; Cudkowicz, M.; Atasi, N. Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS). Amyotroph. Lateral Scler. Frontotemporal Degener 2014, 15, 453–456. [Google Scholar] [CrossRef]
- De Carvalho, M.; Kiernan, M.C.; Swash, M. Fasciculation in amyotrophic lateral sclerosis: origin and pathophysiological relevance. J. Neurol. Neurosurg. Psychiatry 2017, 88, 773–779. [Google Scholar] [CrossRef] [PubMed]
- Ludolph, A.C.; Knirsch, U. Problems and pitfalls in the diagnosis of ALS. J. Neurol. Sci. 1999, 165, S14-520. [Google Scholar] [CrossRef] [PubMed]
- Falcão de Campos, C.; Gromicho, M.; Uysal, H.; Grosskreutz, J.; Kuzma-Kozakiewicz, M.; Oliveira Santos, M.; Pinto, S.; Petri, S.; Swash, M.; de Carvalho, M. Trends in the diagnostic delay and pathway for amyotrophic lateral sclerosis patients across different countries. Front. Neurol. 2023, 13, 1064619. [Google Scholar] [CrossRef] [PubMed]
- Corcia, P.; Bede, P.; Pradat, P.F.; Couratier, P.; Vucic, S.; De Carvalho, M. Split-hand and split-limb phenomena in amyotrophic lateral sclerosis: pathophysiology, electrophysiology and clinical manifestations. J. Neurol. Neurosurg. Psychiatry 2021, 92, 1126–1130. [Google Scholar] [CrossRef]

| Variable | Non-Surgery Group (N=284) | Surgery Group (N=17) | p-value |
|---|---|---|---|
| Sex | Male: 151 (53.2%) Female: 133 (46.8%) |
Male: 11 (64.7%) Female: 6 (35.3%) |
0.354* |
| Age at Onset (years) | 64.1 (52.5 – 71.8) | 64.12 (52.30 – 70.54) | 0.770 # |
| Diagnostic Delay (months) | 8.99 (5.95 – 15.99) | 14.95 (10.97 – 20.02) | 0.010 # |
| Disease Progression Rate (ΔFS) | 0.72 (0.36 – 1.29) | 0.64 (0.29 – 1.17) | 0.453 # |
| Onset region | Spinal: 208 (73.2%) Nonspinal: 76 (26.8%) |
Spinal: 17 (100.0%) Nonspinal: 0 (0.00%) |
0.014* |
| UMN vs. LMN at Onset | LMN: 223 (78.5%) Predominant UMN: 61 (21.5%) |
LMN: 14 (82.4%) Predominant UMN: 3 (17.6%) |
0.708* |
|
Fasciculations at Onset (N=278) |
Yes: 83 (31.7%) No: 179 (68.3%) |
Yes: 8 (50.0%) No: 8 (50.0%) |
0.129* |
| Reference | Surgical Cases (N) | First Specialist Consulted (%) | Diagnosis (%) | Surgery Procedures (%) |
|---|---|---|---|---|
| This Study | 17 (5.6%) | Surgeon: 5 (29%) Non-Surgeon: 6 (35%) Unknown: 6 (35%) |
Lumbar Sten.: 9 (45%) – 3 OrtS + 6 NS Cerv. Myelopathy: 5 (25%) - 5 NS CTS: 4 (20%) – 4 OrtS Others: 2 (10%) – 1NS + 1OS |
Spinal Decomp..: 14 (70%) CTR: 4 (20%) Other: 2 (10%) |
| Bakola et al. (2014) | 13 (7.9%) | Surgeon: Not specified Non-Surgeon: Not Specified |
Lumbar Sten.: 7 (54%) CTS: 3 (23%) Cerv. Myelopathy: 2 (15%) Others: 1 (8%) |
Spinal Decomp.: 9 (69%) CTR: 3 (23%) Others: 1 (8%) |
| Srinivasan et al. (2006) | 34 (13%) | Surgeon: 12 (35%) Non-Surgeon: 3 (8.8%) Unknown: 19 (55.8%) |
Knee: 12 (32.4%) Lumbar Sten.: 11 (29.7%) Cerv. Myelopathy: 3 (8.1%) CTS: 5 (13.5%) Others: 6 (16.2%) |
Spinal Decomp.: 14 (37.8%) Knee surgery: 12 (32.4%) CTR: 5 (13.5%) Others: 6 (16.2%) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).